{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:15:44Z","timestamp":1743394544662,"version":"3.40.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02511-2","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T06:05:55Z","timestamp":1733378755000},"page":"979-986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lack of correlation between asprosin serum levels and hyperphagic behavior in subjects with prader-Willi Syndrome"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-8337","authenticated-orcid":false,"given":"Maria Felicia","family":"Faienza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Chiarito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Aureli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Buganza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Corica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Fintini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziano","family":"Grugni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Licenziati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Madeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enza","family":"Mozzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Rutigliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2511_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/genes10090713","volume":"10","author":"J Bohonowych","year":"2019","unstructured":"Bohonowych J, Miller J, McCandless SE, Strong TV (2019) The global prader\u2013Willi Syndrome Registry: Development, Launch, and early demographics. Genes 10:713. https:\/\/doi.org\/10.3390\/genes10090713","journal-title":"Genes"},{"key":"2511_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13023-017-0673-6","volume":"12","author":"C Bar","year":"2017","unstructured":"Bar C, Diene G, Molinas C et al (2017) Early diagnosis and care is achieved but should be improved in infants with prader-Willi syndrome. Orphanet J Rare Dis 12:118. https:\/\/doi.org\/10.1186\/s13023-017-0673-6","journal-title":"Orphanet J Rare Dis"},{"key":"2511_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-023-02633-5","volume":"18","author":"M Salvatore","year":"2023","unstructured":"Salvatore M, Torreri P, Grugni G et al (2023) The Italian registry for patients with prader\u2013Willi syndrome. Orphanet J Rare Dis 18:28. https:\/\/doi.org\/10.1186\/s13023-023-02633-5","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2511_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4274\/jcrpe.0029","volume":"10","author":"FM \u00c7izmecio\u011flu","year":"2018","unstructured":"\u00c7izmecio\u011flu FM, Jones JH, Paterson WF et al (2018) Neonatal features of the Prader-Willi Syndrome; the case for making the diagnosis during the First Week of Life. J Clin Res Pediatr Endocrinol 10(3):264\u2013273. https:\/\/doi.org\/10.4274\/jcrpe.0029","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2511_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME (2015) Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38:1249\u20131263. https:\/\/doi.org\/10.1007\/s40618-015-0312-9","journal-title":"J Endocrinol Invest"},{"key":"2511_CR6","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s40618-021-01574-9","volume":"44","author":"G Muscogiuri","year":"2021","unstructured":"Muscogiuri G, Barrea L, Faggiano F et al (2021) Obesity in Prader\u2013Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches. J Endocrinol Invest 44:2057\u20132070. https:\/\/doi.org\/10.1007\/s40618-021-01574-9","journal-title":"J Endocrinol Invest"},{"key":"2511_CR7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","volume":"155","author":"JL Miller","year":"2011","unstructured":"Miller JL, Lynn CH, Driscoll DC et al (2011) Nutritional phases in Prader\u2013Willi syndrome. Am J Med Genet Pt A 155:1040\u20131049. https:\/\/doi.org\/10.1002\/ajmg.a.33951","journal-title":"Am J Med Genet Pt A"},{"key":"2511_CR8","doi-asserted-by":"publisher","unstructured":"Heymsfield SB, Avena NM, Baier L et al (2014) Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia. Obesity 22:. https:\/\/doi.org\/10.1002\/oby.20646","DOI":"10.1002\/oby.20646"},{"key":"2511_CR9","doi-asserted-by":"publisher","first-page":"e0248739","DOI":"10.1371\/journal.pone.0248739","volume":"16","author":"N Kayadjanian","year":"2021","unstructured":"Kayadjanian N, Vrana-Diaz C, Bohonowych J et al (2021) Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome. PLoS ONE 16:e0248739. https:\/\/doi.org\/10.1371\/journal.pone.0248739","journal-title":"PLoS ONE"},{"key":"2511_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cen.12766","volume":"83","author":"KA Irizarry","year":"2015","unstructured":"Irizarry KA, Bain J, Butler MG et al (2015) Metabolic profiling in Prader\u2013Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone. Clin Endocrinol 83:797\u2013805. https:\/\/doi.org\/10.1111\/cen.12766","journal-title":"Clin Endocrinol"},{"key":"2511_CR11","doi-asserted-by":"publisher","first-page":"fcad138","DOI":"10.1093\/braincomms\/fcad138","volume":"5","author":"K Strelnikov","year":"2023","unstructured":"Strelnikov K, Debladis J, Salles J et al (2023) Amygdala hyperactivation relates to eating behaviour: a potential indicator of food addiction in prader\u2013Willi syndrome. Brain Commun 5:fcad138. https:\/\/doi.org\/10.1093\/braincomms\/fcad138","journal-title":"Brain Commun"},{"key":"2511_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J et al (2016) Asprosin, a Fasting-Induced glucogenic protein hormone. Cell 165:566\u2013579. https:\/\/doi.org\/10.1016\/j.cell.2016.02.063","journal-title":"Cell"},{"key":"2511_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nm.4432","volume":"23","author":"C Duerrschmid","year":"2017","unstructured":"Duerrschmid C, He Y, Wang C et al (2017) Asprosin is a centrally acting orexigenic hormone. Nat Med 23:1444\u20131453. https:\/\/doi.org\/10.1038\/nm.4432","journal-title":"Nat Med"},{"key":"2511_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cmet.2022.02.012","volume":"34","author":"I Mishra","year":"2022","unstructured":"Mishra I, Xie WR, Bournat JC et al (2022) Protein tyrosine phosphatase receptor \u03b4 serves as the orexigenic asprosin receptor. Cell Metabol 34:549\u2013563e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.012","journal-title":"Cell Metabol"},{"key":"2511_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cell.2012.12.022","volume":"152","author":"J-W Sohn","year":"2013","unstructured":"Sohn J-W, Harris LE, Berglund ED et al (2013) Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152:612\u2013619. https:\/\/doi.org\/10.1016\/j.cell.2012.12.022","journal-title":"Cell"},{"key":"2511_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/ped.14176","volume":"62","author":"E S\u00fcnnet\u00e7i Silistre","year":"2020","unstructured":"S\u00fcnnet\u00e7i Silistre E, Hatipo\u011fl HU (2020) Increased serum circulating asprosin levels in children with obesity. Pediatr Int 62:467\u2013476. https:\/\/doi.org\/10.1111\/ped.14176","journal-title":"Pediatr Int"},{"key":"2511_CR17","doi-asserted-by":"publisher","first-page":"103095","DOI":"10.1016\/j.dsx.2024.103095","volume":"18","author":"JR Ulloque-Badaracco","year":"2024","unstructured":"Ulloque-Badaracco JR, Al-kassab-C\u00f3rdova A, Hernandez-Bustamante EA et al (2024) Asprosin levels in patients with type 2 diabetes mellitus, metabolic syndrome and obesity: a systematic review and meta-analysis. Diabetes Metabolic Syndrome: Clin Res Reviews 18:103095. https:\/\/doi.org\/10.1016\/j.dsx.2024.103095","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"2511_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","volume":"35","author":"M Alan","year":"2019","unstructured":"Alan M, Gurlek B, Yilmaz A et al (2019) Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 35:220\u2013223. https:\/\/doi.org\/10.1080\/09513590.2018.1512967","journal-title":"Gynecol Endocrinol"},{"key":"2511_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12519-021-00444-x","volume":"17","author":"L-J Liu","year":"2021","unstructured":"Liu L-J, Kang Y-R, Xiao Y-F (2021) Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity. World J Pediatr 17:394\u2013399. https:\/\/doi.org\/10.1007\/s12519-021-00444-x","journal-title":"World J Pediatr"},{"key":"2511_CR20","doi-asserted-by":"publisher","first-page":"155184","DOI":"10.1016\/j.cyto.2020.155184","volume":"134","author":"F Ke","year":"2020","unstructured":"Ke F, Xue G, Jiang X et al (2020) Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. Cytokine 134:155184. https:\/\/doi.org\/10.1016\/j.cyto.2020.155184","journal-title":"Cytokine"},{"key":"2511_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12944-021-01514-9","volume":"20","author":"N Moradi","year":"2021","unstructured":"Moradi N, Fouani FZ, Vatannejad A et al (2021) Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study. Lipids Health Dis 20:88. https:\/\/doi.org\/10.1186\/s12944-021-01514-9","journal-title":"Lipids Health Dis"},{"key":"2511_CR22","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.3390\/jcm11082268","volume":"11","author":"M Alsaif","year":"2022","unstructured":"Alsaif M, Field CJ, Colin-Ramirez E et al (2022) Serum asprosin concentrations in children with prader\u2013Willi Syndrome: correlations with metabolic parameters. JCM 11:2268. https:\/\/doi.org\/10.3390\/jcm11082268","journal-title":"JCM"},{"issue":"7","key":"2511_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF03344156","volume":"29","author":"E Cacciari","year":"2006","unstructured":"Cacciari E, Milani S, Balsamo A et al (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 year). J Endocrinol Invest 29(7):581\u2013593. https:\/\/doi.org\/10.1007\/BF03344156","journal-title":"J Endocrinol Invest"},{"key":"2511_CR24","doi-asserted-by":"publisher","first-page":"829486","DOI":"10.3389\/fped.2022.829486","volume":"10","author":"MR Licenziati","year":"2022","unstructured":"Licenziati MR, Bacchini D, Crin\u00f2 A et al (2022) The Hyperphagia Questionnaire: insights from a multicentric validation study in individuals with Prader Willi Syndrome. Front Pediatr 10:829486. https:\/\/doi.org\/10.3389\/fped.2022.829486","journal-title":"Front Pediatr"},{"issue":"7","key":"2511_CR25","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/oby.2007.216","volume":"15","author":"EM Dykens","year":"2007","unstructured":"Dykens EM, Maxwell MA, Pantino E, Kossler R, Roof E (2007) Assessment of hyperphagia in Prader-Willi syndrome. Obes (Silver Spring) 15(7):1816\u20131826. https:\/\/doi.org\/10.1038\/oby.2007.216","journal-title":"Obes (Silver Spring)"},{"key":"2511_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1034\/j.1399-5448.2003.t01-1-00022.x","volume":"4","author":"WS Cutfield","year":"2003","unstructured":"Cutfield WS, Jefferies CA, Jackson WE et al (2003) Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children: HOMA and QUICKI. Pediatr Diabetes 4:119\u2013125. https:\/\/doi.org\/10.1034\/j.1399-5448.2003.t01-1-00022.x","journal-title":"Pediatr Diabetes"},{"key":"2511_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000503808","volume":"75","author":"M Wang","year":"2019","unstructured":"Wang M, Yin C, Wang L et al (2019) Serum asprosin concentrations are increased and Associated with insulin resistance in children with obesity. Ann Nutr Metab 75:205\u2013212. https:\/\/doi.org\/10.1159\/000503808","journal-title":"Ann Nutr Metab"},{"key":"2511_CR28","doi-asserted-by":"publisher","first-page":"155477","DOI":"10.1016\/j.cyto.2021.155477","volume":"142","author":"D Corica","year":"2021","unstructured":"Corica D, Aversa T, Curr\u00f2 M et al (2021) Asprosin serum levels and glucose homeostasis in children with obesity. Cytokine 142:155477. https:\/\/doi.org\/10.1016\/j.cyto.2021.155477","journal-title":"Cytokine"},{"key":"2511_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000500523","volume":"91","author":"W Long","year":"2019","unstructured":"Long W, Xie X, Du C et al (2019) Decreased circulating levels of Asprosin in obese children. Horm Res Paediatr 91:271\u2013277. https:\/\/doi.org\/10.1159\/000500523","journal-title":"Horm Res Paediatr"},{"key":"2511_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12902-024-01565-w","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang Y, Yang B et al (2024) Circulating levels of asprosin in children with obesity: a systematic review and meta-analysis. BMC Endocr Disord 24:36. https:\/\/doi.org\/10.1186\/s12902-024-01565-w","journal-title":"BMC Endocr Disord"},{"key":"2511_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","volume":"43","author":"C-Y Wang","year":"2019","unstructured":"Wang C-Y, Lin T-A, Liu K-H et al (2019) Serum asprosin levels and bariatric surgery outcomes in obese adults. Int J Obes 43:1019\u20131025. https:\/\/doi.org\/10.1038\/s41366-018-0248-1","journal-title":"Int J Obes"},{"key":"2511_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5603\/EP.a2022.0093","volume":"74","author":"G Hu","year":"2023","unstructured":"Hu G, Si W, Zhang Q, Lv F (2023) Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case-control study. Endokrynol Pol 74:55\u201362. https:\/\/doi.org\/10.5603\/EP.a2022.0093","journal-title":"Endokrynol Pol"},{"key":"2511_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13098-020-00564-w","volume":"12","author":"S Naiemian","year":"2020","unstructured":"Naiemian S, Naeemipour M, Zarei M et al (2020) Serum concentration of asprosin in new-onset type 2 diabetes. Diabetol Metab Syndr 12:65. https:\/\/doi.org\/10.1186\/s13098-020-00564-w","journal-title":"Diabetol Metab Syndr"},{"key":"2511_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","volume":"489","author":"L Zhang","year":"2019","unstructured":"Zhang L, Chen C, Zhou N et al (2019) Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta 489:183\u2013188. https:\/\/doi.org\/10.1016\/j.cca.2017.10.034","journal-title":"Clin Chim Acta"},{"key":"2511_CR35","doi-asserted-by":"publisher","first-page":"20573","DOI":"10.1038\/s41598-023-48024-5","volume":"13","author":"L Matesevac","year":"2023","unstructured":"Matesevac L, Vrana-Diaz CJ, Bohonowych JE et al (2023) Analysis of Hyperphagia Questionnaire for clinical trials (HQ-CT) scores in typically developing individuals and those with prader-Willi syndrome. Sci Rep 13:20573. https:\/\/doi.org\/10.1038\/s41598-023-48024-5","journal-title":"Sci Rep"},{"key":"2511_CR36","doi-asserted-by":"publisher","first-page":"1101091","DOI":"10.3389\/fendo.2022.1101091","volume":"13","author":"M Farrag","year":"2023","unstructured":"Farrag M, Ait Eldjoudi D, Gonz\u00e1lez-Rodr\u00edguez M et al (2023) Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol 13:1101091. https:\/\/doi.org\/10.3389\/fendo.2022.1101091","journal-title":"Front Endocrinol"},{"key":"2511_CR37","doi-asserted-by":"publisher","first-page":"1382583","DOI":"10.3389\/fendo.2024.1382583","volume":"15","author":"SF Madeo","year":"2024","unstructured":"Madeo SF, Zagaroli L, Vandelli S et al (2024) Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation. Front Endocrinol 15:1382583. https:\/\/doi.org\/10.3389\/fendo.2024.1382583","journal-title":"Front Endocrinol"},{"key":"2511_CR38","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s40618-021-01533-4","volume":"44","author":"MF Faienza","year":"2021","unstructured":"Faienza MF, Brunetti G, Grugni G et al (2021) The genetic background and vitamin D supplementation can affect irisin levels in prader\u2013Willi syndrome. J Endocrinol Invest 44:2261\u20132271. https:\/\/doi.org\/10.1007\/s40618-021-01533-4","journal-title":"J Endocrinol Invest"},{"key":"2511_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1210\/jc.2014-3127","volume":"100","author":"D Lacroix","year":"2015","unstructured":"Lacroix D, Moutel S, Coupaye M et al (2015) Metabolic and adipose tissue signatures in adults with prader-Willi Syndrome: a model of Extreme Adiposity. J Clin Endocrinol Metabolism 100:850\u2013859. https:\/\/doi.org\/10.1210\/jc.2014-3127","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2511_CR40","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1210\/jc.2016-2163","volume":"101","author":"M Coupaye","year":"2016","unstructured":"Coupaye M, Tauber M, Cuisset L et al (2016) Effect of genotype and previous GH treatment on adiposity in adults with prader-Willi Syndrome. J Clin Endocrinol Metabolism 101:4895\u20134903. https:\/\/doi.org\/10.1210\/jc.2016-2163","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2511_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jir.12140","volume":"59","author":"V Laurier","year":"2015","unstructured":"Laurier V, Lapeyrade A, Copet P et al (2015) Medical, psychological and social features in a large cohort of adults with P rader\u2013 W illi syndrome: experience from a dedicated centre in France. J Intellect Disabil Res 59:411\u2013421. https:\/\/doi.org\/10.1111\/jir.12140","journal-title":"J Intellect Disabil Res"},{"key":"2511_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5603\/EP.a2020.0059","volume":"72","author":"N Gozel","year":"2021","unstructured":"Gozel N, Kilinc F (2021) Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin. Endokrynol Pol 72:37\u201343. https:\/\/doi.org\/10.5603\/EP.a2020.0059","journal-title":"Endokrynol Pol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02511-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T08:44:09Z","timestamp":1743324249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02511-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"Written consent was obtained from all participants and their parents, after having informed them of the purpose of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Informed Consent"}}]}}